1. Home
  2. CAE vs MRNA Comparison

CAE vs MRNA Comparison

Compare CAE & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAE
  • MRNA
  • Stock Information
  • Founded
  • CAE 1947
  • MRNA 2010
  • Country
  • CAE Canada
  • MRNA United States
  • Employees
  • CAE N/A
  • MRNA N/A
  • Industry
  • CAE
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CAE
  • MRNA Health Care
  • Exchange
  • CAE Nasdaq
  • MRNA Nasdaq
  • Market Cap
  • CAE 8.5B
  • MRNA 9.2B
  • IPO Year
  • CAE N/A
  • MRNA 2018
  • Fundamental
  • Price
  • CAE $25.85
  • MRNA $24.55
  • Analyst Decision
  • CAE Buy
  • MRNA Hold
  • Analyst Count
  • CAE 4
  • MRNA 15
  • Target Price
  • CAE $33.75
  • MRNA $36.69
  • AVG Volume (30 Days)
  • CAE 504.3K
  • MRNA 12.0M
  • Earning Date
  • CAE 11-11-2025
  • MRNA 11-06-2025
  • Dividend Yield
  • CAE N/A
  • MRNA N/A
  • EPS Growth
  • CAE N/A
  • MRNA N/A
  • EPS
  • CAE 0.97
  • MRNA N/A
  • Revenue
  • CAE $3,470,482,234.00
  • MRNA $2,232,000,000.00
  • Revenue This Year
  • CAE $4.63
  • MRNA N/A
  • Revenue Next Year
  • CAE $5.99
  • MRNA $10.38
  • P/E Ratio
  • CAE $26.54
  • MRNA N/A
  • Revenue Growth
  • CAE 9.12
  • MRNA N/A
  • 52 Week Low
  • CAE $20.36
  • MRNA $23.04
  • 52 Week High
  • CAE $30.13
  • MRNA $48.92
  • Technical
  • Relative Strength Index (RSI)
  • CAE 31.96
  • MRNA 45.63
  • Support Level
  • CAE $26.17
  • MRNA $24.18
  • Resistance Level
  • CAE $28.35
  • MRNA $27.10
  • Average True Range (ATR)
  • CAE 0.79
  • MRNA 1.57
  • MACD
  • CAE -0.18
  • MRNA -0.03
  • Stochastic Oscillator
  • CAE 3.23
  • MRNA 27.76

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: